Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis

Background. This study evaluated the effectiveness of managing posterior blepharitis (PB) using a novel Posterior Blepharitis Management Protocol (PBMP). Design. Prospective, consecutive case series with 100% followup to one month. Participants. 27 patients (54 eyes) with PB from an Ophthalmology pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Steven T. H. Yun, David M. Woo, Calum W. K. Chong, Ying Liu, Katherine E. Francis, Saumil A. Shah, Ashish Agar, Ian C. Francis
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2015/617019
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850218342839746560
author Steven T. H. Yun
David M. Woo
Calum W. K. Chong
Ying Liu
Katherine E. Francis
Saumil A. Shah
Ashish Agar
Ian C. Francis
author_facet Steven T. H. Yun
David M. Woo
Calum W. K. Chong
Ying Liu
Katherine E. Francis
Saumil A. Shah
Ashish Agar
Ian C. Francis
author_sort Steven T. H. Yun
collection DOAJ
description Background. This study evaluated the effectiveness of managing posterior blepharitis (PB) using a novel Posterior Blepharitis Management Protocol (PBMP). Design. Prospective, consecutive case series with 100% followup to one month. Participants. 27 patients (54 eyes) with PB from an Ophthalmology practice in Sydney, Australia. Methods. Each patient’s PB was assessed by grading the nature and expressibility of the central lower lid tarsal gland secretions on Compression Of The Eyelid (COTE). Patients were then instructed in detail to undertake daily PB management sessions at home using our modified PBMP. Main Outcome Measures. On a subjective scale, patients compared their symptoms at one month with baseline. COTE scores were reevaluated to assess the objective effectiveness of each individual’s PBMP. COTE scoring was described as grades 1 (clear oil), 2 (pus, liquid), 3 (toothpaste-like secretions), and 4 (complete tarsal gland obstruction). Results. Patients reported a mean 77.8% ± 13.5% subjective improvement in symptoms. There was a trend towards improvement in COTE grading at one month compared with baseline: grades 1 (0 to 7.4%), 2a (22.2 to 16.6%), 2b (7.4 to 3.7%), 3 (18.5 to 27.7%), and 4 (51.8 to 44%). Conclusions. PBMP provided a rapid, inexpensive, simple, effective, and safe method of treating PB.
format Article
id doaj-art-36e6354f1e70417fa965a90f62d1d0b7
institution OA Journals
issn 2090-004X
2090-0058
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-36e6354f1e70417fa965a90f62d1d0b72025-08-20T02:07:46ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/617019617019Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior BlepharitisSteven T. H. Yun0David M. Woo1Calum W. K. Chong2Ying Liu3Katherine E. Francis4Saumil A. Shah5Ashish Agar6Ian C. Francis7The Department of Ophthalmology, Prince of Wales Hospital, Sydney, NSW 2031, AustraliaThe Department of Ophthalmology, Prince of Wales Hospital, Sydney, NSW 2031, AustraliaThe University of New South Wales, Sydney, NSW 2052, AustraliaThe University of New South Wales, Sydney, NSW 2052, AustraliaThe Department of Ophthalmology, Prince of Wales Hospital, Sydney, NSW 2031, AustraliaThe University of New South Wales, Sydney, NSW 2052, AustraliaThe Department of Ophthalmology, Prince of Wales Hospital, Sydney, NSW 2031, AustraliaThe Department of Ophthalmology, Prince of Wales Hospital, Sydney, NSW 2031, AustraliaBackground. This study evaluated the effectiveness of managing posterior blepharitis (PB) using a novel Posterior Blepharitis Management Protocol (PBMP). Design. Prospective, consecutive case series with 100% followup to one month. Participants. 27 patients (54 eyes) with PB from an Ophthalmology practice in Sydney, Australia. Methods. Each patient’s PB was assessed by grading the nature and expressibility of the central lower lid tarsal gland secretions on Compression Of The Eyelid (COTE). Patients were then instructed in detail to undertake daily PB management sessions at home using our modified PBMP. Main Outcome Measures. On a subjective scale, patients compared their symptoms at one month with baseline. COTE scores were reevaluated to assess the objective effectiveness of each individual’s PBMP. COTE scoring was described as grades 1 (clear oil), 2 (pus, liquid), 3 (toothpaste-like secretions), and 4 (complete tarsal gland obstruction). Results. Patients reported a mean 77.8% ± 13.5% subjective improvement in symptoms. There was a trend towards improvement in COTE grading at one month compared with baseline: grades 1 (0 to 7.4%), 2a (22.2 to 16.6%), 2b (7.4 to 3.7%), 3 (18.5 to 27.7%), and 4 (51.8 to 44%). Conclusions. PBMP provided a rapid, inexpensive, simple, effective, and safe method of treating PB.http://dx.doi.org/10.1155/2015/617019
spellingShingle Steven T. H. Yun
David M. Woo
Calum W. K. Chong
Ying Liu
Katherine E. Francis
Saumil A. Shah
Ashish Agar
Ian C. Francis
Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis
Journal of Ophthalmology
title Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis
title_full Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis
title_fullStr Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis
title_full_unstemmed Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis
title_short Utilisation of a Novel Test to Measure Severity and Treatment Efficacy of Posterior Blepharitis
title_sort utilisation of a novel test to measure severity and treatment efficacy of posterior blepharitis
url http://dx.doi.org/10.1155/2015/617019
work_keys_str_mv AT steventhyun utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis
AT davidmwoo utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis
AT calumwkchong utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis
AT yingliu utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis
AT katherineefrancis utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis
AT saumilashah utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis
AT ashishagar utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis
AT iancfrancis utilisationofanoveltesttomeasureseverityandtreatmentefficacyofposteriorblepharitis